Two in vivo experiments indicated that oral mTOR inhibitors (everolimus and sirolimus) significantly reduced the progression of PF, including peritoneal thickness, vascularity, and fibrosis score, in a rat model induced by CG (Duman et al., 2008; Ceri et al., 2012). The gene discussed is MTOR; the disease is pemphigus foliaceus.